A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effects of 10 mg and 25 mg doses of
asoprisnil, compared to placebo, taken daily for 12 weeks, on uterine blood flow and the
morphology of the endometrium and uterine fibroids.